Western Blot Protocol
Principle
Western blotting (WB), a widely adopted analytical method, is employed to detect specific target proteins within complex samples using antigen-specific antibodies. This technique serves the purpose of identifying individual proteins and allows for semi-quantitative analysis. It encompasses three fundamental processes: size-based separation through gel electrophoresis, subsequent transfer to a solid support via blotting, and visualization of the target protein through probing.
Gel electrophoresis is utilized to separate sample proteins based on their polypeptide lengths. These separated proteins are subsequently transferred onto a nitrocellulose (NC) membrane, where they are subjected to probing with a primary antibody specific to the target protein antigen. Typically, the membrane is incubated with an antibody against the antigen of interest, followed by a secondary antibody, leading to the eventual detection of the target protein.
Material
| Reagents | Instruments and Consumables |
| Loading Buffer | Eppendorf Tube |
| Running Buffer | Eppendoff |
| Transfer Buffer | Centrifuge |
| Washing Buffer (PBST) | Incubation Plate |
| Blocking Buffer | Oscillating Table |
| Chemiluminescent Substrate | Electrophresis Apparatus |
| Protein Maker | Transfer Tank |
| Primary Antibody | Imager |
| Secondary Antibody-HRP |
Procedure
Fig. 1 The workflow of WB.
Hot products
PDCD1 HIV1 gp120 CD33 IAV HA PRNP TNF MS4A1 CD274 APP EGFR CD40 ERBB3 TFPI ERBB2 SARS-CoV S PCSK9 MET BSG HAVCR2 IL6 CD3 LAG3 ROR1 TNFRSF4 IL33 CD19 CD38 JAG1 IL17A IFNG CD47 HCV E2 Protein IL1A / IL1B HBsAg IGF1R CD4 AXL ANGPT2 IL23A NGF MUC1 TNFRSF18 TNFRSF9 MSTN IL1B HRSV F Protein KDR SORT1 C5 VEGF CXCR4 TNFRSF17 Tau TFRC CTLA4 IL13 IAV H5N1 HA TSLP MSLN SOST
Application
Fig. 2 BC069792 regulates KCNQ4 as a downstream target gene.1
This study investigated the function of long non-coding RNA BC069792 in breast cancer: Conducting in vitro and in vivo functional experiments utilizing cell culture and murine models. Protein expression assessed via WB and immunohistochemical staining reveals a significant increase in KCNQ4 protein levels in the BC069792 overexpression group compared to the control group.
Creative Biolabs provides comprehensive services pertaining to WB, for additional details, feel free to contact us without hesitation.
Reference
- Zhang, Yunxiang, et al. "LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer." Molecular cancer 22.1 (2023): 1-19. Distributed under Open Access license CC BY 4.0, without modification.
